imipramine has been researched along with milnacipran in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, S; Horisawa, T; Kato, T; Kinomura, N; Kodo, T; Koyama, K; Masumoto, S; Matsumoto, K; Matsumoto, Y; Oki, H; Yabuuchi, K; Yoshinaga, H | 1 |
| Briley, M; Moret, C | 2 |
| Kawasaki, H; Nuki, C; Takasaki, K; Tasaki, H; Urabe, M; Yamamoto, R | 1 |
| Bauer, M; Fauran-Clavel, MJ; LaCabanne, C; Lamure, A; Megret, C | 1 |
| Adamantidis, MM; Dupuis, BA; Rouet, RH; Tisne-Versailles, J; Vincent, A | 1 |
| Chartres, JP; Léger, JM; Pezous, N; Plétan, Y; Pujol-Domenech, J; Tignol, J; Tonelli, I; Tournoux, A | 1 |
| Hashimoto, S; Hattori, T; Kawasaki, K; Kitamura, Y; Miki, N; Mochizuki, D; Otsuka, Y; Tsujita, R; Yamada, S | 1 |
| Barbagli, B; Boissard, R; Fort, P; Gervasoni, D; Henninot, V; Luppi, PH; Panconi, E | 1 |
| Ferrey, G; Tournoux, A; Van Amerongen, AP | 1 |
| Conesa, A; Lopez-Ibor, JJ | 1 |
| Aoki, M; Chiba, H; Harada, Y; Matsumiya, T; Nohara, J; Takeda, H; Tsuji, M | 1 |
| Hazui, T; Hori, S; Matsuo, N; Miki, A; Nakano, M; Ohtani, H; Sawada, Y; Suzuki, Y; Yagi, H; Yamamoto, A | 1 |
| Inoue, T; Iwamoto, N; Izumi, T; Kato, A; Kitaichi, Y; Koyama, T | 1 |
| Hayashi, H; Sukma, M; Tanaka, K; Tohda, M | 1 |
| Bantsiele, GB; Bentué-Ferrer, D; Bourin, M; Laviolle, B; Reymann, JM; Saïkali, S | 1 |
| Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T | 1 |
| Adachi-Akahane, S; Hoshiai, K; Koizumi, S; Matsumoto, M; Mitsumori, Y; Nagayama, Y; Nakamura, Y; Sugiyama, A | 1 |
| Nowak, G; Pilc, A; Poleszak, E; Popik, P; Siwek, A; Szewczyk, B; Wolak, M | 1 |
| Harada, S; Matsuura, W; Tokuyama, S | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for imipramine and milnacipran
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for imipramine and milnacipran
| Article | Year |
|---|---|
Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode.
Topics: Adrenergic Uptake Inhibitors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclopropanes; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Milnacipran; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1998 |
A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depression.
Topics: Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Double-Blind Method; Drug Tolerance; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Milnacipran | 2002 |
A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclopropanes; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Milnacipran; Treatment Outcome | 2004 |
19 other study(ies) available for imipramine and milnacipran
| Article | Year |
|---|---|
Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT
Topics: Animals; Antidepressive Agents; Cytochrome P-450 CYP2D6 Inhibitors; Dioxanes; Drug Partial Agonism; Humans; Male; Piperidines; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Plasma Membrane Transport Proteins | 2017 |
Effect of antidepressant drugs on monoamine synthesis in brain in vivo.
Topics: Animals; Antidepressive Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Citalopram; Clorgyline; Cyclopropanes; Desipramine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Haloperidol; Hydrazines; Imipramine; Male; Milnacipran; Norepinephrine; Organ Specificity; Parietal Lobe; Rats; Rats, Wistar; Serotonin; Tyrosine 3-Monooxygenase | 1992 |
[Electroencephalographic and cardiovascular effects of milnaciplan hydrochloride (TN-912), a novel antidepressant].
Topics: Animals; Antidepressive Agents; Blood Pressure; Brain; Cyclopropanes; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electroencephalography; Guinea Pigs; Heart Rate; Imipramine; In Vitro Techniques; Male; Maprotiline; Milnacipran; Myocardial Contraction; Rats; Rats, Inbred Strains; Respiration | 1991 |
Differential scanning calorimetry study of the interaction of antidepressant drugs, noradrenaline, and 5-hydroxytryptamine with a membrane model.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antidepressive Agents; Buffers; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Cyclopropanes; Imipramine; Membranes, Artificial; Milnacipran; Models, Theoretical; Norepinephrine; Octanols; Piperidines; Serotonin; Solubility; Temperature | 1990 |
Comparative in vivo and in vitro study of the cardiac effects of midalcipran and imipramine.
Topics: Action Potentials; Animals; Antidepressive Agents; Cyclopropanes; Electrophysiology; Female; Guinea Pigs; Heart; Imipramine; In Vitro Techniques; Infusions, Intravenous; Male; Membrane Potentials; Milnacipran; Myocardial Contraction; Papillary Muscles; Potassium | 1989 |
High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
Topics: Amitriptyline; Animals; Citalopram; Clomipramine; Cyclopropanes; Hypothalamus; Imipramine; Kinetics; Male; Milnacipran; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium | 1986 |
Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; Conditioning, Psychological; Cyclopropanes; Dose-Response Relationship, Drug; Fear; Fluoxetine; Fluvoxamine; Imipramine; Male; Maprotiline; Microdialysis; Milnacipran; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Prefrontal Cortex; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cell Surface; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Synaptosomes; Time Factors | 2002 |
Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclopropanes; Imipramine; Male; Milnacipran; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Stages; Sleep, REM; Wakefulness | 2002 |
Antidepressants enhance the antinociceptive effects of carbamazepine in the acetic acid-induced writhing test in mice.
Topics: Acetic Acid; Analgesics, Non-Narcotic; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Carbamazepine; Cyclopropanes; Fluvoxamine; Imipramine; Male; Mice; Mice, Inbred ICR; Milnacipran; Pain; Pain Measurement | 2006 |
Piloerection induced by replacing fluvoxamine with milnacipran.
Topics: Adult; Antidepressive Agents; Cyclopropanes; Female; Fluvoxamine; Humans; Imipramine; Milnacipran; Models, Biological; Norepinephrine; Panic Disorder; Piloerection | 2007 |
Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Cyclopropanes; Drug Interactions; Imipramine; Male; Mianserin; Milnacipran; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Syndrome | 2007 |
BNIP-3: a novel candidate for an intrinsic depression-related factor found in NG108-15 cells treated with Hochu-ekki-to, a traditional oriental medicine, or typical antidepressants.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apoptosis; Brain; Chromatography, High Pressure Liquid; Cyclopropanes; Depressive Disorder; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gene Expression Profiling; Gene Expression Regulation; Hybridomas; Imipramine; Medicine, East Asian Traditional; Membrane Proteins; Mianserin; Mice; Milnacipran; Mitochondrial Proteins; Neurons; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Tumor Cells, Cultured; Up-Regulation | 2008 |
Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety Disorders; Behavior, Animal; Brain Ischemia; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Fluvoxamine; Hippocampus; Imipramine; Immobility Response, Tonic; Male; Milnacipran; Motor Activity; Rats; Rats, Wistar | 2009 |
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger | 2009 |
In vivo canine model comparison of cardiovascular effects of antidepressants milnacipran and imipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Tricyclic; Cyclopropanes; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Hemodynamics; Imipramine; Infusions, Intravenous; Long QT Syndrome; Male; Milnacipran; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Time Factors; Ventricular Function | 2010 |
Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test.
Topics: 2-Amino-5-phosphonovalerate; Animals; Antidepressive Agents; Citalopram; Cyclopropanes; Imipramine; Immobility Response, Tonic; Male; Mice; Milnacipran; Morpholines; Motor Activity; N-Methylaspartate; Oxazines; Quinoxalines; Reboxetine; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2013 |
Effects of Adjuvant Analgesics on Cerebral Ischemia-Induced Mechanical Allodynia.
Topics: Amines; Analgesics; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Brain Ischemia; Carbamazepine; Chemotherapy, Adjuvant; Cyclohexanecarboxylic Acids; Cyclopropanes; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Imipramine; Indomethacin; Male; Mexiletine; Mice; Milnacipran; Morphine; Neuralgia; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2016 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results | 2011 |